Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study to Evaluate the Efficacy and Safety of the BreathID® System for Detection of Cirrhosis Using the ¹³C-methacetin Breath Test(MBT)

NCT00736840 is registered in ClinicalTrials.gov with Meridian Bioscience, Inc. as lead sponsor.

NCT NCT00736840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study to Evaluate the Efficacy and Safety of the BreathID® System for Detection of Cirrhosis Using the ¹³C-methacetin Breath Test(MBT)
Lead sponsor
Meridian Bioscience, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
September 30, 2009
Enrollment
414 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease